Journal of Sports Science and Medicine
Journal of Sports Science and Medicine
ISSN: 1303 - 2968   
Ios-APP Journal of Sports Science and Medicine
Views
10826
Download
1522
from September 2014
 
©Journal of Sports Science and Medicine (2011) 10, 238 - 253

Review article
Current Opinions on Tendinopathy
Jean-François Kaux1, , Bénédicte Forthomme1, Caroline Le Goff2, Jean-Michel Crielaard1, Jean-Louis Croisier1
Author Information
1 Physical Medicine Service and Department of Motility Sciences,
2 Department of Biomedical and Preclinical Sciences, University Hospital, University of Liege, Liège Belgium

Jean-François Kaux
✉ Physical Medicine Service and Department of Motility Sciences, University Hospital, University of Liege, Avenue de l’Hôpital, B35, B-4000 Liège Belgium
Email: jfkaux@chu.ulg.ac.be
Publish Date
Received: 03-01-2011
Accepted: 21-02-2011
Published (online): 01-06-2011
 
 
ABSTRACT

Tendinopathy is characterized by pain in the tendon and impaired performance sometimes associated with swelling of the tendon. Its diagnosis is usually clinical but ultrasonography and magnetic resonance imaging can refine the diagnosis. Tendinopathy is highly prevalent and is one of the most frequently self reported musculoskeletal diseases in physical workers and sports people. Nevertheless, it is very difficult to carry out general epidemiologic studies on tendinopathy because of the varying sports cultures and sports habits in different countries. The aetiology of tendinopathy seems to be multi-factorial, involving intrinsic and extrinsic factors. The role of inflammation is still debated but the absence of inflammatory cells does not mean that inflammatory mediators are not implicated. Different theories have been advanced to explain pain and chronicity mechanisms, but these mechanisms remain largely unknown. “Conventional ”treatments are generally employed empirically to fight pain and inflammation but they do not modify the histological structure of the tendon. However, these treatments are not completely satisfactory and the recurrence of symptoms is common. Currently, eccentric training remains the treatment of choice for tendinopathy, even though some studies are contradictory. Moreover, many interesting new treatments are now being developed to treat tendinopathy, but there is little evidence to support their use in clinical practice.

Key words: Aetiology, epidemiology, inflammation, tendinopathy, therapeutic advances, treatments


           Key Points
  • The word “tendinopathy ”is the correct term for the clinical diagnosis of pain accompanied by impaired performance, and sometimes swelling in the tendon.
  • The aetiology of tendinopathy seems to be a multi-factorial process, involving promoting factors that are intrinsic or extrinsic, working either alone or in combination.
  • US (with color Doppler) and MRI are usually prescribed when tendinopathy is unresponsive to treatment and entails lingering symptoms.
  • Eccentric training is currently considered to be the most efficient treatment for tendinopathy; nevertheless, in order to be effective, this treatment needs specific modalities: slow speed, low intensity and gradual intensification, with minimum 20 to 30 sessions of exercises often being needed.
  • Many interesting new treatments are now being developed to treat tendinopathy, but currently there is little evidence to support their use in clinical practice.
 
 
Home Issues About Authors
Contact Current Editorial board Authors instructions
Email alerts In Press Mission For Reviewers
Archive Scope
Supplements Statistics
Most Read Articles
  Most Cited Articles
 
  
 
JSSM | Copyright 2001-2024 | All rights reserved. | LEGAL NOTICES | Publisher

It is forbidden the total or partial reproduction of this web site and the published materials, the treatment of its database, any kind of transition and for any means, either electronic, mechanic or other methods, without the previous written permission of the JSSM.

This work is licensed under a Creative Commons License Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.